Dorzolamide/Timolol Labatec 20.0 mg/ml, 5.0 mg/ml, collyre en solution
7680685960016
CH-68596
S01ED51
11.09.0.
1 / 2
google
Details
- Product number
- 6859601
- CPT
- -
- Packaging group
- 5
- Unit
- ml
- Composition
- dorzolamidum 20 mg ut dorzolamidi hydrochloridum 22.26 mg, timololum 5 mg ut timololi maleas 6.83 mg, benzalkonii chloridum 75 µg, natrii citras dihydricus, hydroxyethylcellulosum, natrii hydroxidum, mannitolum, aqua ad iniectabile ad solutionem pro 1 ml.
Articles (1)
Dorzolamide/Timolol Labatec 20.0 mg/ml, 5.0 mg/ml, collyre en solution
Augentropfen
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
22.26 MG | Substance | WIZUS |
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
6.83 MG | Substance | WIZUS |
|
(N/A)
|
75.0 UG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 68596
- Drug name
- Dorzolamide/Timolol Labatec, collyre en solution
- Galenic form
- AUL
- ATC Code
- S01ED51
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 07/07/2022
- Authorization expiration date
- 06/07/2027
- IT number
- 11.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DORZOLAMIDE/TIMOLOL Labatec gtt opht 5 ml
- Description (DE)
- DORZOLAMIDE/TIMOLOL Labatec Gtt Opht 5 ml
- Narcotic (BTM)
- No